Surface expression and CEA binding of hnRNP M4 protein in HT29 colon cancer cells.
Carcinoembryonic antigen (CEA) has been shown to participate in the progression and metastatic growth of colorectal cancer. However, its biological function remains elusive. Recently, we found that CEA protects colon cancer cells from undergoing apoptosis, suggesting a complex role that includes signal transduction activity. Additionally, it was reported that CEA binds to Kupffer cells and macrophages to a membrane-anchored homolog of heterogeneous nuclear protein M4 (hnRNP M4), which subsequently was named CEA-receptor (CEAR). Cytoplasmatic and membranous expression of CEAR in CEA-positive colon cancer tissues prompted us to analyze the CEA-CEAR interaction in HT29 colon cancer cells. Both, CEA and CEAR were found on the cell surface of HT29 cells, as demonstrated by confocal microscopy. Imaging analysis suggested co-localization and, thus, interaction of both molecules. To confirm this observation, immunoprecipitation experiments and Western blot analysis were performed and indicated binding of CEA and CEAR. Immunoprecipitation of CEA resulted in a pull down of CEAR. The pull down of CEAR correlated with the amount of CEA as demonstrated by ribozyme targeting of CEA. Finally, external treatment of HT29 cells with soluble CEA induced tyrosine phosphorylation of CEAR, suggesting a CEA-dependent role of CEAR in signal transduction. Future experiments will elucidate whether the CEA-CEAR interaction is involved in CEA's antiapoptotic role and mediates the prometastatic properties of CEA in colon cancer cells.
Laguinge
Luciana
L
Department of Oncology and Surgery, Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Bajenova
Olga
O
Bowden
Emma
E
Sayyah
Jacqueline
J
Thomas
Peter
P
Juhl
Hartmut
H
D000818:Animals; D002272:Carcinoembryonic Antigen / Q000096:biosynthesis / Q000378:metabolism* / Q000494:pharmacology; D002462:Cell Membrane / Q000276:immunology / Q000378:metabolism; D003110:Colonic Neoplasms / Q000276:immunology / Q000378:metabolism*; D019073:HT29 Cells; D034761:Heterogeneous-Nuclear Ribonucleoprotein Group M / Q000096:biosynthesis / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D047468:Immunoprecipitation; D016676:Macrophages, Alveolar / Q000276:immunology / Q000378:metabolism; D051379:Mice; D010766:Phosphorylation / Q000187:drug effects; D034781:Receptors, N-Acetylglucosamine / Q000096:biosynthesis / Q000378:metabolism*
D002272:Carcinoembryonic Antigen; C440104:HNRNPM protein, human; D034761:Heterogeneous-Nuclear Ribonucleoprotein Group M; D034781:Receptors, N-Acetylglucosamine